Approval · Notice of Compliance 3165 · 1998
NU-VALPROIC: Notice of Compliance 3165
Issued June 15, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3165
- Date
- June 15, 1998
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE SYRUP (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-VALPROIC | 02238069 | Approved |
Medicinal ingredients
- VALPROIC ACID 50 MG per ML